Supernus Pharmaceuticals (SUPN) Prepaid Assets (2011 - 2026)

Supernus Pharmaceuticals (SUPN) reported Prepaid Assets of $78.1 million for Q1 2026, up 169.93% year-over-year from $28.9 million in Q1 2025, and up 19.55% quarter-over-quarter from $65.3 million in Q4 2025.

Supernus Pharmaceuticals (SUPN) Prepaid Assets (2011 - 2026) Analysis & Trends

Supernus Pharmaceuticals (SUPN) has 16 years of Prepaid Assets data on file, last reported at $78.1 million in Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $78.1 million, up 169.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.1 million (up 169.93% YoY), and the FY2025 annual result was $65.3 million, up 81.02% from the prior year.
  • Prepaid Assets grew to $78.1 million in Q1 2026 per SUPN's latest filing, from $65.3 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $78.1 million in Q1 2026 and troughed at $15.8 million in Q4 2022.
  • A 5-year average of $33.1 million and a median of $24.8 million in 2022 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2024 and 2026: Prepaid Assets plunged 48.25% in 2024, then jumped 169.93% in 2026.
  • A 5-year view of Prepaid Assets shows it stood at $15.8 million in 2022, then grew by 5.68% to $16.7 million in 2023, then soared by 116.41% to $36.1 million in 2024, then jumped by 81.02% to $65.3 million in 2025, then climbed by 19.55% to $78.1 million in 2026.
  • Business Quant data shows SUPN's Prepaid Assets at $78.1 million in Q1 2026, $65.3 million in Q4 2025, and $62.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Supernus Pharmaceuticals 2.63 Bn 2.24 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 78.09 Mn
Dec 31, 2025 65.33 Mn
Sep 30, 2025 62.08 Mn
Jun 30, 2025 31.42 Mn
Mar 31, 2025 28.93 Mn
Dec 31, 2024 36.09 Mn
Sep 30, 2024 27.40 Mn
Jun 30, 2024 23.17 Mn
Mar 31, 2024 23.77 Mn
Dec 31, 2023 16.68 Mn
Sep 30, 2023 23.93 Mn
Jun 30, 2023 44.77 Mn
Mar 31, 2023 16.30 Mn
Dec 31, 2022 15.78 Mn
Sep 30, 2022 24.85 Mn
Jun 30, 2022 21.41 Mn
Mar 31, 2022 22.37 Mn
Dec 31, 2021 27.02 Mn
Sep 30, 2021 30.69 Mn
Jun 30, 2021 33.74 Mn